Brain aneurysm rupture, COVID-19 exposure in utero, socioeconomics and brain development.
In this week's podcast, Neurology Today's editor-in-chief discusses RAAS inhibitors for brain aneurysm rupture, the impact of COVID-19 on babies exposed in utero, and how socioeconomic status, independent of genetics, affects brain development.
21 Heinä 20224min
Monkeypox, soticelstat for epilepsy, gabapentin for stroke recovery.
In this week's podcast, Neurology Today's editor-in-chief discusses what's known about monkeypox, soticelstat as a potential new epilepsy therapy, and the potential of gabapentin for stroke recovery.
7 Heinä 20224min
Fenfluramine for LGS, social isolation and dementia risk, neurology's status in NRMP match.
In this week's podcast, Neurology Today's editor-in-chief discusses the approval of fenfluramine for Lennox-Gastaut syndrome, how social isolation affects dementia risk, and the competitiveness of neurology in this year's residency match.
16 Kesä 20224min
Teleneurology in rural America, trauma-informed neurology,advances in neurogenetics
In this week's podcast, Neurology Today's editor-in-chief discusses the challenges and opportunities of teleneurology in rural areas, the effect of childhood trauma on neurologic disorders, and genetics advances in neurology.
2 Kesä 20225min
Portable MRI for stroke, SSRIs and seizure risk in neonates, neurology training in Ukraine.
In this week's podcast, Neurology Today's editor-in-chief discusses portable low field MRI for stroke, SSRI exposure in pregnancy and risk for seizures in neonates, and disrupted neurology training in Ukraine.
19 Touko 20225min
Blood pressure trajectories, Parkinson's risk factors, neurology residents, Potamkin Award
In this week's podcast, Neurology Today's editor-in-chief discusses the link between blood pressure trajectories in young adults and cerebral lesions in midlife, early risk factors for Parkinson's, a newly matched neurology resident, and the winner of the Potamkin Award.
5 Touko 20225min
Gabapentin as a controlled substance embolic stroke of undetermined source, how to become a clinician educator
In this week's podcast, Neurology Today's editor-in-chief discusses the pros/cons of gabapentin as a controlled substance, recurrent stroke risk in adults with embolic stroke of unknown source, how to become a clinician educator.
21 Huhti 20224min
Neurologists in Ukraine, neurology costs discussions, statins and parkinsonism
In this week's podcast, Neurology Today's editor-in-chief discusses the link between statins and parkinsonism, how neurologists in Ukraine are faring, why and how to discuss the costs of care with patients.
7 Huhti 20225min
